BNP PARIBAS FINANCIAL MARKETS - ENZON PHARMACEUTICALS INC ownership

ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 75 filers reported holding ENZON PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ENZON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$38,000
-89.0%
35
-89.5%
0.00%
Q2 2014$346,000
-38.8%
333
-31.6%
0.00%
Q4 2013$565,000
-97.8%
487
-96.1%
0.00%
Q2 2013$25,186,00012,5930.00%
Other shareholders
ENZON PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
HARBERT MANAGEMENT CORP 351,700$703,0000.42%
Baupost Group 7,691,453$15,383,0000.38%
PRICE MICHAEL F 748,200$1,496,0000.20%
Rotella Capital Management, Inc. 25,542$51,0000.16%
Gruss Capital Management LP 517,000$1,034,0000.11%
ALGERT GLOBAL LLC 124,891$250,0000.08%
Spark Investment Management LLC 139,800$267,0000.07%
Icahn Capital 5,904,863$11,810,0000.06%
NWAM LLC 49,326$99,0000.05%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 131,389$262,0000.03%
View complete list of ENZON PHARMACEUTICALS INC shareholders